ABY-035 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
271強直性脊椎炎1

271. 強直性脊椎炎


臨床試験数 : 574 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04795141
(ClinicalTrials.gov)
August 24, 20213/3/2021ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisAnkylosing SpondylitisDrug: ABY-035;Drug: Normal salineInmagene BiopharmaceuticalsAffibodyTerminated18 YearsN/AAll25Phase 2United States;China;Korea, Republic of;Cayman Islands